Cargando…
Dapagliflozin Improves Diabetic Cardiomyopathy by Modulating the Akt/mTOR Signaling Pathway
BACKGROUND: Dapagliflozin can significantly improve heart failure, and Cx43 is one of the molecular mechanisms of heart failure. This study investigated the effect of dapagliflozin on Cx43 and Akt/mTOR signaling pathway in ventricular myocytes. METHODS: A rat model of type 2 diabetes mellitus was es...
Autores principales: | Ren, Mengxiang, Pan, Dabin, Zha, Dayong, Shan, Zeyang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9345717/ https://www.ncbi.nlm.nih.gov/pubmed/35928916 http://dx.doi.org/10.1155/2022/9687345 |
Ejemplares similares
-
Retracted: Dapagliflozin Improves Diabetic Cardiomyopathy by Modulating the Akt/mTOR Signaling Pathway
por: International, BioMed Research
Publicado: (2023) -
Dapagliflozin Alleviates Hepatic Steatosis by Restoring Autophagy via the AMPK-mTOR Pathway
por: Li, Liuran, et al.
Publicado: (2021) -
RRM2 Alleviates Doxorubicin-Induced Cardiotoxicity through the AKT/mTOR Signaling Pathway
por: Jiao, Yuheng, et al.
Publicado: (2022) -
High glucose induces the aging of mesenchymal stem cells via Akt/mTOR signaling
por: Zhang, Dayong, et al.
Publicado: (2017) -
The co-treatment of rosuvastatin with dapagliflozin synergistically inhibited apoptosis via activating the PI3K/AKt/mTOR signaling pathway in myocardial ischemia/reperfusion injury rats
por: Gong, Lei, et al.
Publicado: (2020)